RNS Announcements

ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, is pleased to announce that at the AGM held earlier today, all resolutions were duly passed.

The full voting results will be available on the website in due course here: www.probiotixhealth-ir.com 

This announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement. 

 

For further information, please contact:

ProBiotix Health plc	https://probiotixhealth-ir.com/ investors@probiotixhealth.com
Steen Andersen, Chief Executive Officer Miles Nolan, Investor Relations
AlbR Capital Limited Aquis Corporate Adviser and Broker	Tel: 020 7469 0930
David Coffman Dan Harris

 

Notes to Editors:

ProBiotix Health is a life sciences company that develops probiotic formulations to support cardiometabolic health. Since its formation, ProBiotix has become recognised as a global leader in microbiome modulating probiotics for use in food supplements and nutraceuticals.

The Company has a unique approach; discovering ground breaking probiotics, ensuring their benefits through robust science, and bringing to market effective finished probiotic-based products for human health across the globe.